(SMCX) Defiance Daily Target 2X - Ratings and Ratios
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • • Trading--Leveraged Equity
SMCX: Derivatives, Collateral
The Defiance Daily Target 2X Long SMCI ETF (NASDAQ:SMCX) is an actively managed exchange-traded fund designed to deliver twice the daily percentage change of the underlying security, SMCI. It achieves this through the use of swap agreements, which are financial contracts that allow the fund to gain exposure to the performance of the underlying asset without directly holding it. The fund is classified as non-diversified, meaning it may concentrate its investments in a smaller number of securities, which can increase risk but also potentially amplify returns.
From a technical standpoint, SMCX is currently trading at $58.08, below its 20-day simple moving average (SMA) of $67.45 and its 50-day SMA of $52.86. However, it remains well below its 200-day SMA of $106.11, indicating a significant decline over the longer term. The Average True Range (ATR) of 11.90 suggests moderate volatility, with price swings of approximately 20% over a 20-day period. The average daily trading volume of 4,103,544 shares provides sufficient liquidity for most investors.
Fundamentally, SMCX manages assets under management (AUM) of $383.02 million, positioning it as a mid-sized ETF with adequate scale to maintain market impact while still being agile enough to adjust its positions as needed. The funds focus on delivering leveraged returns makes it a tool for sophisticated investors seeking to capitalize on short-term price movements in SMCI.
Over the next three months, based on the current technical and fundamental data, SMCX is expected to experience continued volatility. The gap between the 20-day SMA and the 200-day SMA suggests bearish momentum, with potential downside risks. However, if SMCI experiences a rebound, the funds 2x leverage could amplify gains. The ATR of 11.90 indicates that price fluctuations will likely remain significant, with potential swings of 15-20% in either direction. Investors should monitor the funds performance closely, as leveraged ETFs are designed for short-term trading and may not be suitable for long-term holding.
Additional Sources for SMCX ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
SMCX ETF Overview
Market Cap in USD | 241m |
Category | Trading--Leveraged Equity |
IPO / Inception | 2024-08-21 |
SMCX ETF Ratings
Growth 5y | -38.5% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength Industry | -76.8 |
Analysts | - |
Fair Price Momentum | 36.94 USD |
Fair Price DCF | - |
SMCX Dividends
No Dividends PaidSMCX Growth Ratios
Growth Correlation 3m | 21.4% |
Growth Correlation 12m | -63.1% |
Growth Correlation 5y | -63.1% |
CAGR 5y | -76.87% |
CAGR/Max DD 5y | -0.81 |
Sharpe Ratio 12m | -0.92 |
Alpha | -133.57 |
Beta | 8.08 |
Volatility | 262.05% |
Current Volume | 2613.5k |
Average Volume 20d | 4662.4k |
As of March 15, 2025, the stock is trading at USD 51.81 with a total of 2,613,500 shares traded.
Over the past week, the price has changed by +17.62%, over one month by -36.58%, over three months by +7.16% and over the past year by -76.87%.
Probably not. Based on ValueRay Analyses, Defiance Daily Target 2X (NASDAQ:SMCX) is currently (March 2025) not a good stock to buy. It has a ValueRay Growth Rating of -38.51 and therefor a somwhat technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SMCX as of March 2025 is 36.94. This means that SMCX is currently overvalued and has a potential downside of -28.7%.
Defiance Daily Target 2X has no consensus analysts rating.
According to ValueRays Forecast Model, SMCX Defiance Daily Target 2X will be worth about 44.3 in March 2026. The stock is currently trading at 51.81. This means that the stock has a potential downside of -14.44%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 44.3 | -14.4% |